O'Shaughnessy Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-1,413
Closed -$33.2K – 2120
2024
Q2
$33.2K Buy
+1,413
New +$35.7K ﹤0.01% 1755
2022
Q1
– Sell
-1
Closed – – 1276
2021
Q4
$0 Buy
+1
New +$69 ﹤0.01% 1329

Other funds holding ARKG

O'Shaughnessy Asset Management's ARKG Position: Q3 2024 in Review

O'Shaughnessy Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2024, closing a stake of 1,413 shares — an estimated $33.2K sold.

O'Shaughnessy Asset Management first reported a position in ARKG in Q4 2021 and held it in 2 quarters. The position peaked at $33.2K in Q2 2024. 240 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

  • O'Shaughnessy Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q3 2024 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1,413 ARK Genomic Revolution ETF shares in Q3 2024, an estimated $33.2K.
  • O'Shaughnessy Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 2 quarters.
  • O'Shaughnessy Asset Management's ARK Genomic Revolution ETF position peaked at $33.2K in Q2 2024.
  • 240 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.